General Information
As of 05/25/2012
|
| NAV |
$15.57 |
| NAV Daily Change |
$0.01 |
| % Yield |
.82 |
| % SEC Yield |
N/A |
| % YTD Return (as of 04/30/2012) |
7.78 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL LB |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
4.32 |
| Net Assets (Mil $) N/A |
75.12 |
| % Turnover N/A |
83.63 |
Fees
|
| % Max Sales Load |
.00 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.00 |
| % Max Management Fee |
1.00 |
| % Redemption Fee |
.00 |
| % Expense Ratio |
1.36 |
Allocation
|
| Large Growth |
.00 |
| Large Value |
16.68 |
| Small Growth |
.00 |
| Small Value |
9.57 |
| Foreign Stock |
3.43 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
.00 |
| Foreign Bond |
27.93 |
| High Yield Bond |
20.16 |
Portfolio Information |
| Composition |
| As of N/A |
% of Net Assets |
| Stock |
99.28 |
| Cash |
.78 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.00 |
| Foreign Stock |
5.41 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-.07 |
Sector / Country Weightings
|
| As of 12/31/2011 |
% of Portfolio |
| Health |
73.27 |
| Retail Trade |
10.00 |
| Finance |
7.82 |
| Services |
3.85 |
| Industrial Cyclical |
3.25 |
| Technology |
1.09 |
| Other |
.72 |
| N/A |
N/A |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 12/31/2011) |
% of Portfolio |
Value (Mil$) |
|
| PFIZER INC |
10.87 |
7.76 |
| MERCK + CO. INC. |
8.38 |
5.98 |
| ABBOTT LABORATORIES |
6.43 |
4.59 |
| JOHNSON + JOHNSON |
5.97 |
4.26 |
| AMGEN INC |
5.18 |
3.70 |
| ELI LILLY + CO |
4.35 |
3.10 |
| CELGENE CORP |
4.33 |
3.10 |
| UNITED THERAPEUTICS |
3.98 |
2.84 |
| GILEAD SCIENCES INC |
3.85 |
2.75 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now  |
Fund Description
|
The fund was incepted in February 1997 and is managed by Icon Advisers, Inc. The fund seeks long-term capital appreciation using a quantitative methodology to identify securities Icon believes are under priced relative to value. The fund invests at least 80% of its net assets in equity securities of companies in the healthcare sector and traded in the U.S. equity securities in which the fund may invest include common and preferred stocks of companies of any market capitalization. The fund distributes dividends and capital gains, if any, annually.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
N/A |
| Total Issues |
37 |
| Avg. P/E |
23.56 |
| Avg. P/Book |
5.71 |
| Avg. EPS Growth |
16.96 |
| Avg. Market Value (Mil $) |
64,633 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.67 |
0.70 |
0.68 |
| Alpha |
4.88 |
-1.06 |
-0.34 |
| R Squared |
0.65 |
0.67 |
0.55 |
| Std. Dev. |
12.89 |
16.50 |
14.58 |
| Sharpe |
1.46 |
-0.04 |
4.00 |
Shareholder Information
|
| Manager |
Scott Callahan |
| Since |
01/09 |
| Manager Rating * SEE EXPLANTION |
.1 |
| Inception Date |
02/24/1997 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$1,000 |
| Minimum Subsequent Investment |
$100 |
| IRA Minimum |
$0 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
ICON Funds |
| Address |
5299 DTC Blvd, 12th Fl
Greenwood Village, CO 80111 |
| Phone |
800 828-4881 |
|
Sponsored Links 
